MX9305183A - PORTABLE INTRON, VIRAL GENOMIC DNA MOLECULA, LIVE VIRUS AND CONTAINING VACCINE AND METHOD FOR OBTAINING IT. - Google Patents

PORTABLE INTRON, VIRAL GENOMIC DNA MOLECULA, LIVE VIRUS AND CONTAINING VACCINE AND METHOD FOR OBTAINING IT.

Info

Publication number
MX9305183A
MX9305183A MX9305183A MX9305183A MX9305183A MX 9305183 A MX9305183 A MX 9305183A MX 9305183 A MX9305183 A MX 9305183A MX 9305183 A MX9305183 A MX 9305183A MX 9305183 A MX9305183 A MX 9305183A
Authority
MX
Mexico
Prior art keywords
intron
portable
gene
sequence
animal
Prior art date
Application number
MX9305183A
Other languages
Spanish (es)
Inventor
John D Reilly
Robert F Silva
Original Assignee
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Agriculture filed Critical Us Agriculture
Publication of MX9305183A publication Critical patent/MX9305183A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/30—Bird
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

El intrón portátil de esta invención es una molécula de ADN aislada la cual contiene, en el orden desde el extremo 5' al extremo 3' una secuencia donadora de empalme o unión, una secuencia de clonación múltiple, una secuencia aceptora de la rama de lazo o estructura sigma, una secuencia rica en pirimidina y una secuencia aceptora de empalme. Cuando se inserta un gen extraño en un sitio de clonación múltiple del intrón portátil, y el intrón portátil se inserta dentro de un gen huésped en la orientación apropiada, tanto el gen extraño como el gen del huésped pueden ser transcritos y expresados de manera simultánea. Alternativamente, el intrón portátil puede ser insertado dentro del gen huésped de una manera la cual permita la expresión del gen extraño sin expresión del gen huésped. El intrón portátil es útil para expresar en un animal un gen no se expresa normalmente en el animal, o para corregir un defecto en la expresión del animal del gen. El intrón portátil también es útil para inhibir una función única de una proteína multifuncional expresada por un gen huésped.The portable intron of this invention is an isolated DNA molecule which contains, in the order from the 5 'end to the 3' end a junction or junction donor sequence, a multiple cloning sequence, an acceptor sequence of the loop branch or sigma structure, a sequence rich in pyrimidine and a splice acceptor sequence. When a foreign gene is inserted into a multiple cloning site of the portable intron, and the portable intron is inserted into a host gene in the proper orientation, both the foreign gene and the host gene can be transcribed and expressed simultaneously. Alternatively, the portable intron can be inserted into the host gene in a manner that allows expression of the foreign gene without expression of the host gene. The portable intron is useful for expressing a gene in an animal not normally expressed in the animal, or for correcting a defect in the animal's expression of the gene. The portable intron is also useful for inhibiting a unique function of a multifunctional protein expressed by a host gene.

MX9305183A 1992-08-27 1993-08-26 PORTABLE INTRON, VIRAL GENOMIC DNA MOLECULA, LIVE VIRUS AND CONTAINING VACCINE AND METHOD FOR OBTAINING IT. MX9305183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93642392A 1992-08-27 1992-08-27

Publications (1)

Publication Number Publication Date
MX9305183A true MX9305183A (en) 1994-05-31

Family

ID=25468609

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305183A MX9305183A (en) 1992-08-27 1993-08-26 PORTABLE INTRON, VIRAL GENOMIC DNA MOLECULA, LIVE VIRUS AND CONTAINING VACCINE AND METHOD FOR OBTAINING IT.

Country Status (3)

Country Link
AU (1) AU4839493A (en)
MX (1) MX9305183A (en)
WO (1) WO1994005784A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641670A (en) * 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
US5968502A (en) * 1991-11-05 1999-10-19 Transkaryotic Therapies, Inc. Protein production and protein delivery
US6270989B1 (en) 1991-11-05 2001-08-07 Transkaryotic Therapies, Inc. Protein production and delivery
AU738395B2 (en) * 1994-05-13 2001-09-20 Transkaryotic Therapies, Inc. DNA construct for effecting homologous recombination and uses thereof
US5561053A (en) * 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
IL131746A0 (en) * 1997-03-14 2001-03-19 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
US5830698A (en) * 1997-03-14 1998-11-03 Idec Pharmaceuticals Corporation Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA858044B (en) * 1984-11-01 1987-05-27 American Home Prod Oral vaccines
US4981791A (en) * 1988-06-27 1991-01-01 Health Research Incorporated RNA stabilization vector
US5043270A (en) * 1989-03-31 1991-08-27 The Board Of Trustees Of The Leland Stanford Junior University Intronic overexpression vectors

Also Published As

Publication number Publication date
WO1994005784A1 (en) 1994-03-17
AU4839493A (en) 1994-03-29

Similar Documents

Publication Publication Date Title
Sampietro et al. The genetics of the pre‐Roman Iberian Peninsula: A mtDNA study of ancient Iberians
Strand et al. Protein kinase and phosphate acceptor proteins in Rauscher murine leukaemia virus
Greenwood et al. Nuclear insertion sequences of mitochondrial DNA predominate in hair but not in blood of elephants
DK0544894T3 (en) Use of exo-sample nucleotides in gene cloning
ES2154624T1 (en) REGULATION OF THE EXPRESSION OF THE FOSFORRIBOSIL TRANSFER QUINOLATE.
CY1114192T1 (en) LENDI-VICTORY BODY
DK1228227T3 (en) Hankönssterile Brassica plants and methods for their preparation
CO4650231A1 (en) LIVING AVIARY RECOMBINANT VACCINE USING THE AVIARY LARYNTHRACHEITIS VIRUS AS A VECTOR
CY1112430T1 (en) LENGTHENING TRIPLE DNA AND VEHICLES AND RECOVERY CELLS CONTAINING LENGTHENING TRIPLE DNA
NO20003058D0 (en) Mass spectrometric methods for sequencing nucleic acids
HUP9902571A2 (en) Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
ATE330007T1 (en) METHOD FOR INCREASE THE EXPRESSION OF ENDOGENE OR EXOGENEOUS GENE PRODUCTS IN PLANTS
CY1109439T1 (en) Analogues of Glycoprotein Disulfide Crosslinked Hormones, Their Preparation and Use
DK1054893T3 (en) Synthetic polymers and methods, kits or compositions for modulating their solubility
HK1105662A1 (en) Sequences from natural or synthetic retroelements having the function of allowing the insertion of nucleotide sequences in a eukaryotic cell
MX9305183A (en) PORTABLE INTRON, VIRAL GENOMIC DNA MOLECULA, LIVE VIRUS AND CONTAINING VACCINE AND METHOD FOR OBTAINING IT.
Bernhard et al. Evolution of histone H4 and H3 genes in different ciliate lineages
DK1471926T3 (en) Compositions and Methods for Therapeutic Use of an Atonal-Associated Sequence
ES2059436T3 (en) PROTEIN OF THE EXTERNAL MEMBRANE F OF PSEUDOMONAS AERUGINOSA.
DK1173594T3 (en) Methods for delivering inhibitory RNA to plants and their use
ATE493499T1 (en) RESISTANCE TO PESTS
BR0311191A (en) Combination
CO5650177A2 (en) GENETIC CONSTRUCTS AND COMPOSITIONS THAT INCLUDE RRE AND CTE AND USES OF THESE
ATE236997T1 (en) IMPROVED PRIMERS FOR AFLP AMPLIFICATION
DK1242586T3 (en) RNA polymerases from bacteriophage PHI 6-PHI 14 and their use